Think GLP-1 for the brain: one platform to stop diseases like Parkinson’s and epilepsy at their root. Kiren is building Valaya Bio to silence the master switches driving disease with precision RNA medicines carried into the brain by an IV “Trojan horse.” A two-time biotech founder who built Europe’s largest contract pilot plant for cultivated meat, she is now working with Novo Nordisk’s former Neurobiology Director on multiple patent-protected drug candidates.